Tag: X

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Iovance (IOVA) To Contact Him Directly To Discuss Their Options

TALLINN, Estonia, July 12, 2025 (GLOBE NEWSWIRE) -- With interest in blockchain innovation surging, Bitcoin Solaris (BTC-S) is making headlines by rolling out a limited-time price rollback during its ongoing presale—now in Phase 11. Originally priced at $11, BTC-S tokens are now available for just $5, giving new buyers access to a lower entry point as the project approaches its official launch.

LAS VEGAS, July 11, 2025 (GLOBE NEWSWIRE) -- Planet 13 Holdings Inc. (CSE: PLTH) (OTCQX: PLNH) (“Planet 13” or the “Company”), a leading vertically-integrated multi-state cannabis company, today announced the full-scale relaunch of its loyalty program. Beginning Friday, July 11, all Planet 13 stores will match any third-party advertised price —a move that firmly positions Planet 13 as the destination offering the Best Product. Best Experience. Best Price.

NEW HAVEN, Conn., July 11, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) has entered into an agreement with its largest warrant holder, amending the existing structure from cash exercise of warrants, to a revised structure whereby 100,000 warrants (approximately ⅓) shall be exercised with cash, and the remainder (approximately 200,000 warrants) to be exercised in a cashless manner.

CAMBRIDGE, Mass., July 11, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.^® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that the company granted non-statutory stock options to a new employee. Fulcrum granted stock options to purchase shares of the company’s common stock pursuant to the company’s 2022 Inducement Stock Incentive Plan, as amended, or the plan, as an inducement material to the new employee entering into employment with Fulcrum in accordance with Nasdaq Listing Rule 5635(c)(4).

Transaction in Own Shares